TITLE

Under false pretenses

AUTHOR(S)
Dahir, Mubarak
PUB. DATE
May 1995
SOURCE
Advocate;5/16/95, Issue 681, p34
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the number of participants who routinely cheat on AIDS clinical trial. Estimates on the prevalence of cheating; Advise of researchers against cheating for the benefit of the data and patient's health; Avoidance of cheating by winning the trust of the patient.
ACCESSION #
9509245612

 

Related Articles

  • Peptide-T Passes Initial Test. Helquist, Michael // Advocate;4/12/88, Issue 496, p32 

    Reports that four AIDS patients receiving the experimental anti-AIDS treatment called peptide-T for 30 days showed clinical improvements without experiencing any side effects. Mechanism of action; Intention of the U.S. government to give exclusive marketing rights for the drug to the...

  • Giving Researchers a Hand. Helquist, Michael // Advocate;11/26/85, Issue 434, p20 

    Reports on the clinical trials of ribavirin combined with isoprinosine among AIDS patients in San Francisco, California. Benefits of the treatment; Phases of the trial.

  • Judge orders South African health minister to do her job properly. Sidley, Pat // BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1458 

    The article reports that the Cape High Court in South Africa has ruled that drug manufacturer Matthias Rath cannot conduct unauthorized drug trials and that South African health minister Manto Tshabalala-Msimang must enforce drug laws. The South African Medical Association had opposed drug...

  • One-Day HIV Treatment Meeting Near Boston, November 11.  // AIDS Treatment News;9/30/2005, Issue 415, p5 

    Reports that Search for a Cure will hold a one-day free meeting on new drugs, HIV treatment strategies and clinical trials in Boston, Massachusetts on November 11, 2005. Theme of the event; Speakers; Programs and activities.

  • Disclose all data in publications. Baggerly, Keith // Nature;9/23/2010, Vol. 467 Issue 7314, p401 

    The article offers information on the suspension of three clinical trials due to incomplete supporting data involving the confidentiality of cancer patients' data in 2009 at Duke University in Durham, North Carolina.

  • The Safety of Interruption of HAART in Patients Who Never Met the Current Criteria for HIV Treatment Initiation. Deresinski, Stan // Clinical Infectious Diseases;9/15/2006, Vol. 43 Issue 6, pvi 

    The article discusses the research "Safe Treatment interruptions in patients with nadir CD4 counts of more than 350 cells/μL: a randomized trial," published in the 2006 issue of the "Journal of Acquired Immune Deficiency Syndrome" which evaluates the safety of the discontinuation of highly...

  • HIV/AIDS clinical trials critical for minority women, according to study. Townes, Glenn // New York Amsterdam News;8/20/2009, Vol. 100 Issue 34, p26 

    The article presents information on the study GRACE (Gender, Race and Clinical Experience) which analyzes race and gender differences. It notes that the study conducted a clinical trial to 287 women and 142 men with HIV by a therapy regimen which includes the drug Prezista (darunavir) and Norvir...

  • India refuses patent protection for two key HIV drugs.  // HIV/AIDS Policy & Law Review;Dec2009, Vol. 14 Issue 2, p28 

    The article reports that the Indian Patent Office (IPO) has rejected applications for patents from two U.S. pharmaceutical companies for tenofovir and darunavir. IPO finds that clinical trials did not prove that the new compounds were effective and gained support from international civil society...

  • Viral Genetics Begins Phase 1 Clinical Trial for Ovarian Cancer.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that the first patient has been enrolled for the for the Viral Genetics Inc. sponsored clinical trial of Metabolic Disruption Technology compounds along with a cancer therapy for the treatment of ovarian cancer. It further informs that Viral Genetics is working on the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics